Long-term kidney allograft survival in patients with transplant glomerulitis

Transplantation

Volumn 99, Issue 2, 2015, Pages 331-339

  Nabokow, Alexander ^a   Dobronravov, Vladimir A ^b   Khrabrova, Maria ^b   Gröne, Hermann Josef ^c   Gröne, Elisabeth ^c   Hallensleben, Michael ^d   Kieneke, Daniela ^d   Weithofer, Peter ^a   Smirnov, Alexei V ^b   Kliem, Volker ^a  

^a Lower Saxony Center of Nephrology   (Germany)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULITIS; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; RENAL TRANSPLANT GLOMERULITIS; RETROSPECTIVE STUDY; SURVIVAL TIME; ADULT; ADVERSE EFFECTS; ALLOGRAFT; BLOOD; CHI SQUARE DISTRIBUTION; GLOMERULONEPHRITIS; GRAFT REJECTION; IMMUNOLOGY; KAPLAN MEIER METHOD; KIDNEY TRANSPLANTATION; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; RISK FACTOR; T LYMPHOCYTE; TIME;

ANTIBODY;

ADULT; ALLOGRAFTS; ANTIBODIES; CHI-SQUARE DISTRIBUTION; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; T-LYMPHOCYTES; TIME FACTORS;

EID: 84922982636     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000606     Document Type: Article

References (27)

1. Sellares J, de Freitas DG, Mengel M, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant. 2012;12:388.
2. Haas M, Sis B, Racusen LC, et al. Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant. 2014;14:272.
3. Sapir-Pichhadze R, Curran SP, John R, et al. A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection. Kidney Int. 2014;87:182-194.
4. Loupy A, Suberbielle-Boissel C, Hill GS, et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant . 2009;9:2561.
5. De Kort H, Willicombe M, Brookes P, et al. Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies. Am J Transplant. 2013;13:485.
6. Sis B, Jhangri GS, Riopel J, et al. A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant. 2012;12:1168.
7. Buob D, Grimbert P, Glowacki F, et al. Three-year outcome of isolated glomerulitis on 3-month protocol biopsies of donor HLA antibody negative patients. Transpl Int. 2012;25:663.
8. Tinckam KJ, Djurdjev O, Magil AB. Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. Kidney Int. 2005;68:1866.
9. Einecke G, Sis B, Reeve J, et al. Antibody-mediatedmicrocirculation injury is the major cause of late kidney transplant failure. Am J Transplant. 2009;9:2520.
10. Batal I, Lunz JG III, Aggarwal N, et al. A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant. 2010;10:2442.
11. Papadimitriou JC, Drachenberg CB, Munivencatappa R, et al. Glomerular inflammation in renal allografts biopsies after the first year. Cell types and relationship with antibody-mediated rejection and graft outcome. Transplantation. 2010;90:1478.
12. Papadimitriou JC, Drachenberg CB, Ramos E, et al. Antibody-mediated allograft rejection: morphologic spectrum and serologic correlations in surveillance and for cause biopsies. Transplantation. 2013;95:128.
13. Verghese P, Dunn T, Najafian B, Kim Y, Matas A. The impact of C4d and microvascular inflammation before we knew them. Clin Transplant. 2013;27:388.
14. Magil AB. Infiltrating cell types in transplant glomerulitis: relationship to peritubular capillary C4d deposition. Am J Kidney Dis. 2005;45:1084-1089.
15. Fahim T, Böhmig GA, Exner M, et al. The cellular lesion of humoral rejection: predominant recruitment of monocytes to peritubular and glomerular capillaries. Am J Transplant. 2007;7:385.
16. Willicombe M, Roufosse C, Brookes P, et al. Acute cellular rejection: impact of donor-specific antibodies and C4d. Transplantation. 2014;97:433.
17. Adeyi OA, Girnita AL, Howe J, et al. Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches. Transpl Immunol. 2005;14:53.
18. Del Bello A, Congy-Jovilet N, Sallusto F, et al. Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy. Clin J Am Soc Nephrol. 2012;7:1310.
19. Terasaki P, Ozawa M, Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant. 2007;7:408.
20. Dragun D, Müller DN, Brasen JH, et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med. 2005;352:558.
21. Giral M, Foucher Y, Dufay A, et al. Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss. Am J Transplant. 2013;13:2567.
22. Taniguchi M, Rebellato LM, Cai J, et al. Higher risk of kidney graft failure in the presence of anti-angiotensin II type 1 receptor antibodies. Am J Transplant. 2013;13:2577.
23. Banasik M, Boratynska M, Koscielska-Kasprzak K, et al. The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes. Transpl Immunol. 2014;30:24.
24. Cardinal H, Dieude M, Brassard N, et al. Anti-perlecan antibodies are novel accelerators of immune-mediated vascular injury. Am J Transplant. 2013;13:861.
25. Bagnasco SM, Zachary AA, Racusen LC, et al. Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients. Transplantation. 2014;97:440.
26. Halloran PF, Pereira AB, Chang J, et al. Microarray diagnosis of antibodymediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM). Am J Transplant. 2013;13:2865.
27. Loupy A, Lefaucheur C, Vernerey D, et al. Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection. J Am Soc Nephrol. 2014;25:2267.